J. Henriksen

发表

Total and high molecular weight (HMW) adiponectin levels and measures of glucose and lipid metabolism following pioglitazone treatment in a randomized placebo‐controlled study in polycystic ovary syndrome

K. Højlund, A. Hermann, J. Frystyk, 2007, Clinical endocrinology.

Effect of pioglitazone on glucose metabolism and luteinizing hormone secretion in women with polycystic ovary syndrome.

H. Beck-Nielsen, A. Hermann, J. Veldhuis, 2006, Fertility and sterility.

Effects of troglitazone in young first-degree relatives of patients with type 2 diabetes.

H. Beck-Nielsen, O. Hother-Nielsen, J. Henriksen, 2004, Diabetes care.

Research Article Amiloride lowers blood pressure and attenuates urine plasminogen activation in patients with treatment-resistant hypertension

L. Tarnow, K. Schousboe, J. Henriksen, 2014 .

Amiloride lowers blood pressure and attenuates urine plasminogen activation in patients with treatment-resistant hypertension.

L. Tarnow, K. Schousboe, J. Henriksen, 2014, Journal of the American Society of Hypertension : JASH.

Low dose spironolactone reduces blood pressure in patients with resistant hypertension and type 2 diabetes mellitus: a double blind randomized clinical trial

L. Tarnow, K. Schousboe, J. Henriksen, 2013, Journal of hypertension.

Mediating the effect of self-care management intervention in type 2 diabetes: a meta-analysis of 47 randomised controlled trials.

Werner Vach, Jan Erik Henriksen, W. Vach, 2010, Patient education and counseling.

Metformin, but Not Rosiglitazone, Attenuates the Increasing Plasma Levels of a New Cardiovascular Marker, Fibulin-1, in Patients With Type 2 Diabetes

J. Henriksen, J. Gram, L. Rasmussen, 2014, Diabetes Care.

The combined effect of triple therapy with rosiglitazone, metformin, and insulin aspart in type 2 diabetic patients.

H. Beck-Nielsen, O. Hother-Nielsen, J. Henriksen, 2003, Diabetes care.

Impact of injection sites for soluble insulin on glycaemic control in Type 1 (insulin-dependent) diabetic patients treated with a multiple insulin injection regimen

A. Vaag, H. Beck-Nielsen, O. Hother-Nielsen, 1993, Diabetologia.

Urinary Markers of Nucleic Acid Oxidation and Long-Term Mortality of Newly Diagnosed Type 2 Diabetic Patients

E. S. Stovgaard, T. Henriksen, J. Henriksen, 2011, Diabetes Care.

Insulin secretion, insulin action, and hepatic glucose production in identical twins discordant for non-insulin-dependent diabetes mellitus.

A. Vaag, H. Beck-Nielsen, J. Henriksen, 1995, The Journal of clinical investigation.

The nicotinic acid analogue acipimox increases plasma leptin and decreases free fatty acids in type 2 diabetic patients.

A. Vaag, H. Beck-Nielsen, J. Vinten, 2000, European journal of endocrinology.

Pronounced blood glucose-lowering effect of the antilipolytic drug acipimox in noninsulin-dependent diabetes mellitus patients during a 3-day intensified treatment period.

A. Vaag, H. Beck-Nielsen, J. Henriksen, 1994, The Journal of clinical endocrinology and metabolism.

Glucose effectiveness and insulin sensitivity measurements derived from the non‐insulin‐assisted minimal model and the clamp techniques are concordant

R. Boston, C. Rantzau, G. Ward, 2010, Diabetes/metabolism research and reviews.

Obesity and coronary risk factors among South Asians

P. McKeigue, M. Marmot, W. Littler, 1991, The Lancet.

Insulin Resistance in Skeletal Muscles in Patients With NIDDM

A. Vaag, H. Beck-Nielsen, A. Handberg, 1992, Diabetes Care.

The metabolic responses induced by acute dexamethasone predict glucose tolerance and insulin secretion over 10 years in relatives of type 2 diabetic subjects

C. Rantzau, G. Ward, H. Beck-Nielsen, 2013, Diabetes/metabolism research and reviews.

Steroid-induced insulin resistance and impaired glucose tolerance are both associated with a progressive decline of incretin effect in first-degree relatives of patients with type 2 diabetes

J. Holst, J. Henriksen, S. Madsbad, 2012, Diabetologia.

Risk and mechanism of dexamethasone-induced deterioration of glucose tolerance in non-diabetic first-degree relatives of NIDDM patients

G. Ward, H. Beck-Nielsen, J. Henriksen, 1997, Diabetologia.

Patients with Type 2 diabetes and ischaemic heart disease have similar coronary flow reserve and endothelial function compared with non‐diabetic patients with ischaemic heart disease

H. Beck-Nielsen, J. Henriksen, T. Haghfelt, 2005, Diabetic medicine : a journal of the British Diabetic Association.

Relationship of glucose concentrations with PAI‐1 and t‐PA in subjects with normal glucose tolerance

J. Henriksen, N. Olivarius, J. Gram, 2006, Diabetic medicine : a journal of the British Diabetic Association.

Effects of mealtime insulin aspart and bedtime neutral protamine Hagedorn insulin on postprandial coagulation and fibrinolysis in patients with type 2 diabetes

J. Henriksen, J. Gram, E. Bladbjerg, 2012, Diabetes, obesity & metabolism.

Marine Food Pollutants as a Risk Factor for Hypoinsulinemia and Type 2 Diabetes

C. Dalgård, P. Grandjean, A. Choi, 2011, Epidemiology.

Low-dose spironolactone reduces plasma fibulin-1 levels in patients with type 2 diabetes and resistant hypertension

L. Tarnow, K. Schousboe, J. Henriksen, 2014, Journal of Human Hypertension.

The prevalence of type 2 diabetes in people with psychiatric disorders: an umbrella review protocol

Kenneth H. Rubin, F. Pouwer, F. Rutters, 2020, Systematic Reviews.

Plasma osteoprotegerin concentrations in peripheral sensory neuropathy in Type 1 and Type 2 diabetic patients

J. Grauslund, J. Henriksen, M. Poulsen, 2009, Diabetic medicine : a journal of the British Diabetic Association.

AKA-TPG: a program for kinetic and epidemiological analysis of data from labeled glucose investigations using the two-pool model and database technology.

R. Boston, G. Ward, P. Moate, 2007, Diabetes technology & therapeutics.

Impaired fasting glycaemia resembles impaired glucose tolerance with regard to cardiovascular risk factors: population‐based, cross‐sectional study of risk factors for cardiovascular disease

J. Henriksen, N. Olivarius, C. Hindsberger, 2004, Diabetic medicine : a journal of the British Diabetic Association.

Insulin resistance: a risk factor for diabetic complications.

A. Vaag, H. Beck-Nielsen, A. Handberg, 1990, The Journal of diabetic complications.

Impairment of glucose tolerance: mechanism of action and impact on the cardiovascular system.

A. Vaag, H. Beck-Nielsen, A. Handberg, 1990, American journal of obstetrics and gynecology.

Correlations between insulin sensitivity and bone mineral density in non‐diabetic men

H. Beck-Nielsen, J. Henriksen, B. Abrahamsen, 2000, Diabetic medicine : a journal of the British Diabetic Association.

Pathophysiology of non-insulin-dependent diabetes mellitus (NIDDM).

A. Vaag, H. Beck-Nielsen, O. Hother-Nielsen, 1995, Diabetes research and clinical practice.

In Vivo Glucose Metabolism, Insulin Secretion and, Insulin Action in Europids with Non‐insulin‐dependent Diabetes Mellitus (NIDDM) and Their First‐degree Relatives

H. Beck-Nielsen, J. Henriksen, F. Alford, 1996, Diabetic medicine : a journal of the British Diabetic Association.

Magnesium, sodium, and potassium content and [3H]ouabain binding capacity of skeletal muscle in relatives of patients with type 2 diabetes: effect of dexamethasone.

J. Henriksen, N. Klitgaard, M. S. Djurhuus, 2002, Metabolism: clinical and experimental.

Oral salmon calcitonin enhances insulin action and glucose metabolism in diet-induced obese streptozotocin-diabetic rats.

M. Karsdal, C. Christiansen, H. Beck-Nielsen, 2014, European journal of pharmacology.

Reproducibility of S-insulin and B-glucose responses in two identical oral glucose tolerance tests

P. H. Petersen, T. Sørensen, K. Kyvik, 2002, Scandinavian journal of clinical and laboratory investigation.

Impact of ubiquinone (coenzyme Q10) treatment on glycaemic control, insulin requirement and well‐being in patients with Type 1 diabetes mellitus

A. Vaag, H. Beck-Nielsen, O. Hother-Nielsen, 1999, Diabetic medicine : a journal of the British Diabetic Association.

A novel syndrome of autosomal-dominant hyperinsulinemic hypoglycemia linked to a mutation in the human insulin receptor gene.

T. Hansen, O. Pedersen, K. Højlund, 2004, Diabetes.

Association Between Urinary Markers of Nucleic Acid Oxidation and Mortality in Type 2 Diabetes

T. Henriksen, J. Henriksen, H. Poulsen, 2013, Diabetes Care.

Elevated levels of sex hormones and sex hormone binding globulin in male patients with insulin dependent diabetes mellitus. Effect of improved blood glucose regulation.

J. Henriksen, C. Hagen, E. Haug, 1997, Danish medical bulletin.

Prevalence of endocrine diseases and abnormal glucose tolerance tests in 340 Caucasian premenopausal women with hirsutism as the referral diagnosis.

K. Schousboe, A. Hermann, D. Glintborg, 2004, Fertility and sterility.

Diabetic nephropathy is associated with increased urine excretion of proteases plasmin, prostasin and urokinase and activation of amiloride-sensitive current in collecting duct cells.

J. Henriksen, B. Jensen, P. Hansen, 2015, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Prevalence and possible mechanisms of reactive hypoglycemia in polycystic ovary syndrome.

D. Glintborg, J. Henriksen, M. Andersen, 2016, Human reproduction.

Effects of mealtime insulin aspart and bedtime NPH insulin on postprandial inflammation and endothelial cell function in patients with type 2 diabetes.

J. Henriksen, J. Gram, E. Bladbjerg, 2011, Basic & clinical pharmacology & toxicology.

A novel oral dual amylin and calcitonin receptor agonist (KBP-042) exerts antiobesity and antidiabetic effects in rats.

M. Karsdal, C. Christiansen, H. Beck-Nielsen, 2014, American journal of physiology. Endocrinology and metabolism.

Variation in Absorption of NPH Insulin Due to Intramuscular Injection

A. Vaag, H. Beck-Nielsen, A. Handberg, 1990, Diabetes Care.

The effect of coenzyme Q10 on blood glucose and insulin requirement in patients with insulin dependent dlabetes mellitus

A. Vaag, H. Beck-Nielsen, O. Hother-Nielsen, 1997 .

The effect of coenzyme Q10 on blood glucose and insulin requirement in patients with insulin dependent diabetes mellitus.

A. Vaag, H. Beck-Nielsen, O. Hother-Nielsen, 1997, Molecular aspects of medicine.

Response to Comment on Vistisen et al. A Validated Prediction Model for End-Stage Kidney Disease in Type 1 Diabetes. Diabetes Care 2021;44:901–907

M. Jørgensen, P. Rossing, F. Persson, 2021, Diabetes Care.

Bone Geometry, Volumetric Density, Microarchitecture, and Estimated Bone Strength Assessed by HR‐pQCT in Adult Patients With Type 1 Diabetes Mellitus

M. Frost, N. Jørgensen, A. Hermann, 2015, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Prediction of First Cardiovascular Disease Event in Type 1 Diabetes Mellitus: The Steno Type 1 Risk Engine

M. Jørgensen, J. Henriksen, D. Vistisen, 2016, Circulation.

Absorption of NPH (Isophane) Insulin in Resting Diabetic Patients: Evidence for Subcutaneous Injection in the Thigh as the Preferred Site

A. Vaag, H. Beck-Nielsen, J. Henriksen, 1991, Diabetic medicine : a journal of the British Diabetic Association.

Impact of family history of diabetes on the assessment of beta-cell function.

A. Vaag, C. Rantzau, G. Ward, 1998, Metabolism: clinical and experimental.

Altered basal and insulin-stimulated phosphotyrosine phosphatase (PTPase) activity in skeletal muscle from NIDDM patients compared with control subjects

H. Beck-Nielsen, P. Staehr, A. Handberg, 1996, Diabetologia.

From housing campaign to multicultural understanding: The development of professional social work in Sámi areas in Norway

J. Henriksen, 2016 .

Left Ventricular Diastolic Function in Type 2 Diabetes Mellitus: Prevalence and Association With Myocardial and Vascular Disease

W. Vach, H. Beck-Nielsen, P. Høilund-Carlsen, 2010, Circulation. Cardiovascular imaging.

Decreased insulin activation of glycogen synthase in skeletal muscles in young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus.

A. Vaag, H. Beck-Nielsen, J. Henriksen, 1992, The Journal of clinical investigation.

Energy expenditure, body composition and insulin response to glucose in male twins discordant for the Trp64Arg polymorphism of the β3‐adrenergic receptor gene

P. Poulsen, K. Højlund, H. Beck-Nielsen, 2006, Diabetes, obesity & metabolism.

Syddansk Universitet Marine food pollutants as a risk factor for hypoinsulinemia and type 2 diabetes

C. Dalgård, P. Grandjean, A. Choi, 2011 .

Exposure to Marine Food Pollutants as a Risk Factor for Hypoinsulinemia and Type 2 Diabetes

C. Dalgård, P. Grandjean, A. Choi, 2010 .

Twin study of genetic and environmental influences on glucose tolerance and indices of insulin sensitivity and secretion

P. Visscher, J. Hopper, T. Sørensen, 2003, Diabetologia.

Fibulin-1 is a marker for arterial extracellular matrix alterations in type 2 diabetes.

H. Parving, S. Knudsen, V. Hjortdal, 2011, Clinical chemistry.

Plasma calprotectin and its association with cardiovascular disease manifestations, obesity and the metabolic syndrome in type 2 diabetes mellitus patients

J. Henriksen, M. Poulsen, M. Nybo, 2014, BMC Cardiovascular Disorders.

Identification of asymptomatic type 2 diabetes mellitus patients with a low, intermediate and high risk of ischaemic heart disease: is there an algorithm?

W. Vach, W. Vach, H. Beck-Nielsen, 2010, Diabetologia.

Significant natriuretic and antihypertensive action of the epithelial sodium channel blocker amiloride in diabetic patients with and without nephropathy

J. Henriksen, F. Nielsen, B. Jensen, 2016, Journal of hypertension.

Pathophysiology‐based phenotyping in type 2 diabetes: A clinical classification tool

I. Brandslund, H. Sørensen, J. Rungby, 2018, Diabetes/metabolism research and reviews.

Magnesium reduces insulin-stimulated glucose uptake and serum lipid concentrations in type 1 diabetes.

J. Henriksen, N. Klitgaard, B. T. Altura, 2001, Metabolism: clinical and experimental.

Improving the relationships between Indigenous rights holders and researchers in the Arctic: an invitation for change in funding and collaboration

T. Herrmann, J. Henriksen, K. Wilson, 2022, Environmental Research Letters.

Plasma copeptin as marker of cardiovascular disease in asymptomatic type 2 diabetes patients

J. Henriksen, M. Poulsen, A. Diederichsen, 2014, Diabetes & vascular disease research.

Intentional Weight Loss and Longevity in Overweight Patients with Type 2 Diabetes: A Population-Based Cohort Study

B. Heitmann, J. Henriksen, M. K. Simonsen, 2016, PloS one.

Plasma osteoprotegerin is related to carotid and peripheral arterial disease, but not to myocardial ischemia in type 2 diabetes mellitus

H. Beck-Nielsen, P. Høilund-Carlsen, J. Henriksen, 2011, Cardiovascular diabetology.

Prevalence of type 2 diabetes in psychiatric disorders: an umbrella review with meta-analysis of 245 observational studies from 32 systematic reviews

Kenneth H. Rubin, F. Pouwer, M. Kivimäki, 2021, Diabetologia.

35th Annual meeting of the European Association for the Study of Diabetes. Brussels, Belgium, 28 September-2 October, 1999. Abstracts.

Thomas J. Smith, B. M. Rasmussen, V. C. Phan, 1999, Diabetologia.

Left atrial volume index: relation to long-term clinical outcome in type 2 diabetes.

T. Hey, H. Beck-Nielsen, P. Høilund-Carlsen, 2013, Journal of the American College of Cardiology.

Do Mandibular Advancement Devices Influence Patients' Snoring and Obstructive Sleep Apnea? A Cone-Beam Computed Tomography Analysis of the Upper Airway Volume.

J. Henriksen, T. Thygesen, Lillian Marcussen, 2015, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

Improving Medication Adherence in Patients with Hypertension: A Randomized Trial.

J. Hallas, A. Pottegård, J. Henriksen, 2015, The American journal of medicine.

Patient explanations for non-attendance at type 2 diabetes self-management education: a qualitative study.

Nete Schwennesen, Jan Erik Henriksen, J. Henriksen, 2016, Scandinavian journal of caring sciences.

Patient Education on Retinopathy

J. Henriksen, L. K. Petersen, M. Rothmann, 2011 .

Pharmacological Treatment of the Pathogenetic Defects in Type 2 Diabetes

H. Beck-Nielsen, J. Henriksen, J. Gram, 2010, Diabetes Care.

Studies of association of AGPAT6 variants with type 2 diabetes and related metabolic phenotypes in 12,068 Danes

T. Hansen, O. Pedersen, N. Grarup, 2013, BMC Medical Genetics.

Insulin allergy can be successfully managed by a systematic approach

C. Bindslev‐Jensen, J. Henriksen, C. Mortz, 2018, Clinical and Translational Allergy.

Glucose effectiveness is a critical pathogenic factor leading to glucose intolerance and type 2 diabetes: An ignored hypothesis

C. Rantzau, H. Beck-Nielsen, J. Henriksen, 2018, Diabetes/metabolism research and reviews.

Endogenous incretin hormone augmentation of acute insulin secretion in normoglycemic relatives of type 2 diabetic subjects: a 10-year retrospective pathophysiological study.

C. Rantzau, H. Beck-Nielsen, J. Henriksen, 2014, The Journal of clinical endocrinology and metabolism.

Urinary markers of nucleic acid oxidation and cancer in type 2 diabetes

S. Friis, T. Henriksen, J. Henriksen, 2014, Redox biology.

Patient preferences for diabetes management among people with type 2 diabetes in Denmark – a discrete choice experiment

T. Vilsbøll, J. Henriksen, J. Faber, 2011, Current medical research and opinion.

The effect of motivational interviewing on glycaemic control and perceived competence of diabetes self-management in patients with type 1 and type 2 diabetes mellitus after attending a group education programme: a randomised controlled trial

J. Hjelmborg, J. Henriksen, L. Minet, 2011, Diabetologia.

Syddansk Universitet The effect of motivational interviewing on glycaemic control and perceived competence of diabetes self-management in patients with type 1 and type 2 diabetes mellitus after attending a group education programme : a randomised controlled trial

J. Hjelmborg, J. Henriksen, L. Wagner, 2011 .

The effect of metformin in overweight patients with type 1 diabetes and poor metabolic control.

H. Beck-Nielsen, J. Henriksen, I. B. Jacobsen, 2009, Basic & clinical pharmacology & toxicology.

Type 2-diabetes. Medicinsk teknologivurdering af screening, diagnostik og behandling

O. Pedersen, K. Borch-Johnsen, T. Bek, 2003 .

Protocol for the specialist supervised individualised multifactorial treatment of new clinically diagnosed type 2 diabetes in general practice (IDA): a prospective controlled multicentre open-label intervention study

H. Beck-Nielsen, M. Olsen, J. Henriksen, 2017, BMJ Open.

Twin study of genetic and environmental influences on adult body size, shape, and composition

P. Visscher, J. Hopper, T. Sørensen, 2004, International Journal of Obesity.

Missing portion sizes in FFQ – alternatives to use of standard portions

B. Heitmann, J. Henriksen, V. Siersma, 2014, Public Health Nutrition.

Compromised cortical bone compartment in type 2 diabetes mellitus patients with microvascular disease.

M. Frost, N. Jørgensen, A. Hermann, 2015, European journal of endocrinology.

Psychiatric disorders as risk factors for the development of type 2 diabetes mellitus: an umbrella review protocol

G. Nefs, F. Pouwer, F. Rutters, 2019, BMJ Open.

Rosiglitazone decreases plasma levels of osteoprotegerin in a randomized clinical trial with type 2 diabetes patients.

J. Henriksen, J. Gram, M. Nybo, 2011, Basic & clinical pharmacology & toxicology.

A novel oral form of salmon calcitonin improves glucose homeostasis and reduces body weight in diet‐induced obese rats

C. Christiansen, H. Beck-Nielsen, J. Henriksen, 2011, Diabetes, obesity & metabolism.

Critical-depth Raman spectroscopy enables home-use non-invasive glucose monitoring

Anders Pors, J. Henriksen, A. Pors, 2018, PloS one.

Prevalence and risk factors for diabetic retinopathy in 17 152 patients from the island of Funen, Denmark

T. Peto, J. Grauslund, J. Henriksen, 2016, Acta ophthalmologica.

Effects of insulin on glucose turnover rates in vivo: isotope dilution versus constant specific activity technique.

J. Holst, H. Beck-Nielsen, O. Hother-Nielsen, 1996, Metabolism: clinical and experimental.

Myocardial ischemia, carotid, and peripheral arterial disease and their interrelationship in type 2 diabetes patients

W. Vach, H. Beck-Nielsen, P. Høilund-Carlsen, 2009, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

Antidiabetic Combination Therapy

H. Beck-Nielsen, J. Henriksen, 2007 .

Educator talk ratio as a quality indicator in group-based patient education

T. Skinner, J. Henriksen, I. Willaing, 2016 .

Evidence-based insulin treatment in type 1 diabetes mellitus.

W. Vach, H. Beck-Nielsen, O. Hother-Nielsen, 2009, Diabetes research and clinical practice.

Patients newly diagnosed with clinical type 2 diabetes during oral glucocorticoid treatment and observed for 14 years: all-cause mortality and clinical developments.

J. Henriksen, T. Drivsholm, N. Olivarius, 2011, Basic & clinical pharmacology & toxicology.

J. Henriksen, V. Siersma, J. Gram, 2011, Scandinavian journal of primary health care.

Intracellular skeletal muscle glucose metabolism is differentially altered by dexamethasone treatment of normoglycemic relatives of type 2 diabetic patients.

A. Vaag, H. Beck-Nielsen, A. Handberg, 1999, Metabolism: clinical and experimental.

Glucose processing during the intravenous glucose tolerance test.

A. Vaag, H. Beck-Nielsen, A. Handberg, 1996, Metabolism: clinical and experimental.

Increased glucose effectiveness in normoglycemic but insulin-resistant relatives of patients with non-insulin-dependent diabetes mellitus. A novel compensatory mechanism.

A. Vaag, G. Ward, H. Beck-Nielsen, 1994, The Journal of clinical investigation.

Impact of family history of diabetes on the assessment of β-cell function

A. Vaag, C. Rantzau, G. Ward, 1998 .

[Reduced synthesis of coenzyme Q10 may cause statin related myopathy].

M. Pareek, J. Henriksen, M. L. Nielsen, 2011, Ugeskrift for laeger.

Counter‐regulatory hormone responses to spontaneous hypoglycaemia during treatment with insulin Aspart or human soluble insulin: a double‐blinded randomized cross‐over study

J. Holst, H. Beck-Nielsen, J. Frystyk, 2011, Acta physiologica.

The Experience of Living With Diabetes Following a Self-Management Program Based on Motivational Interviewing

J. Henriksen, L. Minet, L. Wagner, 2011, Qualitative health research.

Mathematical Beta Cell Model for Insulin Secretion following IVGTT and OGTT

Henrik Madsen, Mats Karlsson, H. Madsen, 2006, Annals of Biomedical Engineering.

Elevated risk of developing type 2 diabetes in people with a psychiatric disorder: What is the role of health behaviors and psychotropic medication?

Kenneth H. Rubin, F. Pouwer, J. Henriksen, 2023, Journal of Diabetes and its Complications.

Common variation in oxidative phosphorylation genes is not a major cause of insulin resistance or type 2 diabetes

T. Hansen, O. Pedersen, N. Grarup, 2012, Diabetologia.

Patients with inflammatory arthropathies undergo feet surgery later in the disease course than hand surgery.

H. Dagfinrud, J. Henriksen, T. Kvien, 2010, Clinical and experimental rheumatology.

Orthopaedic surgery in 255 patients with inflammatory arthropathies: longitudinal effects on pain, physical function and health-related quality of life

H. Dagfinrud, J. Henriksen, P. Mowinckel, 2008, Annals of the rheumatic diseases.

Cohort profile: the Funen Diabetes Database—a population-based cohort of patients with diabetes in Denmark

H. Sørensen, H. Beck-Nielsen, O. Hother-Nielsen, 2020, BMJ Open.

Glucose-mediated glucose disposal in insulin-resistant normoglycemic relatives of type 2 diabetic patients.

J. Holst, H. Beck-Nielsen, O. Hother-Nielsen, 2000, Diabetes.

Glucose effectiveness in nondiabetic relatives: dysglycemia and β-cell function at 10 years.

C. Rantzau, G. Ward, H. Beck-Nielsen, 2014, The Journal of clinical endocrinology and metabolism.

Effects of mealtime insulin aspart and bedtime NPH insulin on postprandial inflammation and endothelial cell function in patients with type 2 diabetes.

J. Henriksen, J. Gram, E. Bladbjerg, 2011, Basic & clinical pharmacology & toxicology.

Myocardial ischemia, carotid, and peripheral arterial disease and their interrelationship in type 2 diabetes patients

W. Vach, H. Beck-Nielsen, P. Høilund-Carlsen, 2009, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

Marine Food Pollutants as a Risk Factor for Hypoinsulinemia and Type 2 Diabetes

C. Dalgård, P. Grandjean, A. Choi, 2011, Epidemiology.

Compromised cortical bone compartment in type 2 diabetes mellitus patients with microvascular disease.

M. Frost, N. Jørgensen, A. Hermann, 2015, European journal of endocrinology.

Mediating the effect of self-care management intervention in type 2 diabetes: a meta-analysis of 47 randomised controlled trials.

W. Vach, J. Henriksen, L. Minet, 2010, Patient education and counseling.

Prevalence and possible mechanisms of reactive hypoglycemia in polycystic ovary syndrome.

D. Glintborg, J. Henriksen, M. Andersen, 2016, Human reproduction.

Accurate Post-Calibration Predictions for Noninvasive Glucose Measurements in People Using Confocal Raman Spectroscopy

G. Freckmann, J. Henriksen, A. Ranjan, 2023, ACS sensors.

Retinal microvascular markers in type 2 diabetes subphenotypes and latent autoimmune diabetes of adults

J. Grauslund, K. Højlund, M. Olsen, 2023, Acta ophthalmologica.